262 related articles for article (PubMed ID: 30983965)
1. Toward a Glutamate Hypothesis of Frontotemporal Dementia.
Benussi A; Alberici A; Buratti E; Ghidoni R; Gardoni F; Di Luca M; Padovani A; Borroni B
Front Neurosci; 2019; 13():304. PubMed ID: 30983965
[TBL] [Abstract][Full Text] [Related]
2. Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure.
Palese F; Bonomi E; Nuzzo T; Benussi A; Mellone M; Zianni E; Cisani F; Casamassa A; Alberici A; Scheggia D; Padovani A; Marcello E; Di Luca M; Pittaluga A; Usiello A; Borroni B; Gardoni F
Neurobiol Aging; 2020 Feb; 86():143-155. PubMed ID: 31784278
[TBL] [Abstract][Full Text] [Related]
3. Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.
Borroni B; Stanic J; Verpelli C; Mellone M; Bonomi E; Alberici A; Bernasconi P; Culotta L; Zianni E; Archetti S; Manes M; Gazzina S; Ghidoni R; Benussi L; Stuani C; Di Luca M; Sala C; Buratti E; Padovani A; Gardoni F
Sci Rep; 2017 Jul; 7(1):6723. PubMed ID: 28751743
[TBL] [Abstract][Full Text] [Related]
4. Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia.
Bracca V; Cantoni V; Gadola Y; Rivolta J; Cosseddu M; Turrone R; Caratozzolo S; Di Luca M; Padovani A; Borroni B; Benussi A
Neurol Sci; 2023 Oct; 44(10):3515-3522. PubMed ID: 37247033
[TBL] [Abstract][Full Text] [Related]
5. GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice.
Scheggia D; Stanic J; Italia M; La Greca F; Zianni E; Benussi A; Borroni B; Di Luca M; Gardoni F
Brain Behav Immun; 2021 Oct; 97():89-101. PubMed ID: 34246733
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical features of frontotemporal dementia.
Procter AW; Qurne M; Francis PT
Dement Geriatr Cogn Disord; 1999; 10 Suppl 1():80-4. PubMed ID: 10436347
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and Frontotemporal Dementia.
Alberici A; Cristillo V; Gazzina S; Benussi A; Padovani A; Borroni B
Curr Alzheimer Res; 2018; 15(7):602-609. PubMed ID: 29357796
[TBL] [Abstract][Full Text] [Related]
8. [Frontotemporal dementia: a review].
Chauvire V; Even C; Thuile J; Rouillon F; Guelfi JD
Encephale; 2007 Dec; 33(6):933-40. PubMed ID: 18789785
[TBL] [Abstract][Full Text] [Related]
9. Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features.
Italia M; Salvadè M; La Greca F; Zianni E; Pelucchi S; Spinola A; Ferrari E; Archetti S; Alberici A; Benussi A; Solje E; Haapasalo A; Hoffmann D; Katisko K; Krüger J; Facchinetti R; Scuderi C; Padovani A; DiLuca M; Scheggia D; Borroni B; Gardoni F
Brain Behav Immun; 2024 May; 118():380-397. PubMed ID: 38485064
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitter deficits from frontotemporal lobar degeneration.
Murley AG; Rowe JB
Brain; 2018 May; 141(5):1263-1285. PubMed ID: 29373632
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies.
Gazzina S; Manes MA; Padovani A; Borroni B
Eur J Pharmacol; 2017 Dec; 817():76-85. PubMed ID: 28579383
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.
Boxer AL; Gold M; Huey E; Gao FB; Burton EA; Chow T; Kao A; Leavitt BR; Lamb B; Grether M; Knopman D; Cairns NJ; Mackenzie IR; Mitic L; Roberson ED; Van Kammen D; Cantillon M; Zahs K; Salloway S; Morris J; Tong G; Feldman H; Fillit H; Dickinson S; Khachaturian Z; Sutherland M; Farese R; Miller BL; Cummings J
Alzheimers Dement; 2013 Mar; 9(2):176-88. PubMed ID: 23043900
[TBL] [Abstract][Full Text] [Related]
13. Precision Medicine for Frontotemporal Dementia.
Liu MN; Lau CI; Lin CP
Front Psychiatry; 2019; 10():75. PubMed ID: 30846947
[TBL] [Abstract][Full Text] [Related]
14. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
van Swieten JC; Heutink P
Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
[TBL] [Abstract][Full Text] [Related]
15. [The neurochemistry and neuropharmacology of frontotemporal dementia].
Alonso-Navarro H; Jabbour-Wadih T; Ayuso-Peralta L; Jiménez-Jiménez FJ
Rev Neurol; 2006 May 1-15; 42(9):556-61. PubMed ID: 16676280
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.
Luis E; Ortiz A; Eudave L; Ortega-Cubero S; Borroni B; van der Zee J; Gazzina S; Caroppo P; Rubino E; D'Agata F; Le Ber I; Santana I; Cunha G; Almeida MR; Boutoleau-Bretonnière C; Hannequin D; Wallon D; Rainero I; Galimberti D; Van Broeckhoven C; Pastor MA; Pastor P
J Alzheimers Dis; 2016 May; 53(1):303-13. PubMed ID: 27163810
[TBL] [Abstract][Full Text] [Related]
17. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
18. Parkinsonism is associated with altered primary motor cortex plasticity in frontotemporal dementia-primary progressive aphasia variant.
Di Stasio F; Suppa A; Fabbrini A; Marsili L; Asci F; Conte A; Trebbastoni A; De Lena C; Berardelli A
Neurobiol Aging; 2018 Sep; 69():230-238. PubMed ID: 29909180
[TBL] [Abstract][Full Text] [Related]
19. C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in
Xu W; Xu J
J Neurosci; 2018 Aug; 38(35):7741-7752. PubMed ID: 30037833
[TBL] [Abstract][Full Text] [Related]
20. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
